Muscle Tissue Bank for Muscular Dystrophy

NCT01950897 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2022-04-26

No results posted yet for this study

Summary

This protocol proposes to establish gene expression profiles of muscular dystrophies for correct diagnosis and for development of experimental therapies for these diseases.

Conditions

  • Muscular Dystrophies
  • Muscular Dystrophy

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Benjamin R Brooks, MD · Medical Director, Carolinas Neuromuscular/ALS-MDA Center, CMC

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-08-24
Primary Completion
2015-01-30
Completion
2015-06-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01950897 on ClinicalTrials.gov